CSTL Annual Cash & Cash Equivalents
$98.84 M
-$24.11 M-19.61%
31 December 2023
Summary:
As of January 22, 2025, CSTL annual cash & cash equivalents is $98.84 million, with the most recent change of -$24.11 million (-19.61%) on December 31, 2023. During the last 3 years, it has fallen by -$311.01 million (-75.88%). CSTL annual cash & cash equivalents is now -75.88% below its all-time high of $409.85 million, reached on December 31, 2020.CSTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Quarterly Cash And Cash Equivalents
$94.96 M
+$9.39 M+10.97%
30 September 2024
Summary:
As of January 22, 2025, CSTL quarterly cash and cash equivalents is $94.96 million, with the most recent change of +$9.39 million (+10.97%) on September 30, 2024. Over the past year, it has dropped by -$3.88 million (-3.93%). CSTL quarterly cash and cash equivalents is now -76.83% below its all-time high of $409.85 million, reached on December 31, 2020.CSTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.6% | -3.9% |
| 3 y3 years | -75.9% | -3.9% |
| 5 y5 years | +2106.8% | -3.9% |
CSTL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.0% | at low | -71.2% | +14.5% |
| 5 y | 5-year | -75.9% | at low | -76.8% | +14.5% |
| alltime | all time | -75.9% | +8054.5% | -76.8% | +2020.1% |
Castle Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $94.96 M(+11.0%) |
| June 2024 | - | $85.57 M(+3.2%) |
| Mar 2024 | - | $82.95 M(-16.1%) |
| Dec 2023 | $98.84 M(-19.6%) | $98.84 M(+8.4%) |
| Sept 2023 | - | $91.22 M(-4.9%) |
| June 2023 | - | $95.87 M(-16.5%) |
| Mar 2023 | - | $114.82 M(-6.6%) |
| Dec 2022 | $122.95 M(-62.7%) | $122.95 M(-8.4%) |
| Sept 2022 | - | $134.18 M(-50.9%) |
| June 2022 | - | $273.17 M(-11.6%) |
| Mar 2022 | - | $309.02 M(-6.3%) |
| Dec 2021 | $329.63 M | $329.63 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $363.18 M(-1.4%) |
| June 2021 | - | $368.34 M(-9.5%) |
| Mar 2021 | - | $406.98 M(-0.7%) |
| Dec 2020 | $409.85 M(+314.6%) | $409.85 M(+123.9%) |
| Sept 2020 | - | $183.05 M(+1.8%) |
| June 2020 | - | $179.76 M(+82.2%) |
| Mar 2020 | - | $98.65 M(-0.2%) |
| Dec 2019 | $98.84 M(+2106.9%) | $98.84 M(+4.6%) |
| Sept 2019 | - | $94.47 M(+440.8%) |
| June 2019 | - | $17.47 M(+7.6%) |
| Mar 2019 | - | $16.23 M(+262.4%) |
| Dec 2018 | $4.48 M(+269.5%) | $4.48 M |
| Dec 2017 | $1.21 M | - |
FAQ
- What is Castle Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Castle Biosciences?
- What is Castle Biosciences annual cash & cash equivalents year-on-year change?
- What is Castle Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Castle Biosciences?
- What is Castle Biosciences quarterly cash and cash equivalents year-on-year change?
What is Castle Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of CSTL is $98.84 M
What is the all time high annual cash & cash equivalents for Castle Biosciences?
Castle Biosciences all-time high annual cash & cash equivalents is $409.85 M
What is Castle Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, CSTL annual cash & cash equivalents has changed by -$24.11 M (-19.61%)
What is Castle Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CSTL is $94.96 M
What is the all time high quarterly cash and cash equivalents for Castle Biosciences?
Castle Biosciences all-time high quarterly cash and cash equivalents is $409.85 M
What is Castle Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, CSTL quarterly cash and cash equivalents has changed by -$3.88 M (-3.93%)